Recent news & coverage.
Company announcements and selected media coverage of Anixa's breast cancer vaccine and ovarian cancer CAR-T programs. For the full archive of press releases and SEC filings, visit investor relations.
Coverage of our work.
Interviews, broadcast features, and analyst conversations about the science behind Anixa’s programs.
Promising breast cancer vaccine advances in trials
Misinformation, hesitancy could blunt impact of new cancer vaccines
A Breast Cancer Vaccine Built to Prevent & Treat
Meet the Disruptors: Amit Kumar Of Anixa Biosciences On 5 Things You Need To Shake Up Your Industry
mRNA Cancer Vaccine Breakthrough: What Moderna and Merck’s Phase 3 Melanoma Result Really Means
A Vaccine To Prevent Breast Cancer Recalibrates The Possible
Outsourcing Everything Is The Biotech Blueprint
Press releases.
Company announcements as issued over the wire. The complete archive lives on the investor relations site.
Peer-reviewed research.
Selected peer-reviewed publications underpinning Anixa’s CAR-T and vaccine programs.
Upcoming events, webcasts & presentations.
Conference appearances, investor webcasts, and the latest corporate presentations are maintained on the investor relations site.
Get Anixa news by email.
Subscribe on our investor relations site to receive press releases and program updates as they’re published.